Research Note · Tracker digest
Registry index

Which existing medicines are being tested for carpal tunnel syndrome?

Compiled by the Open Source Medicine Foundation from the OSMF Research Tracker · Published · Updated · Tracker data refreshes daily

Research information, not medical advice. This page summarises published evidence and registered trials so that you can look further; it does not assess your situation. Talk to your own clinician before acting on anything here. How we select and grade sources

Based on: Carpal Tunnel Syndrome — gene targets, candidate compounds and trials, OSMF Research Tracker (DGIdb, Open Targets, ChEMBL, PubMed and ClinicalTrials.gov data). Numbers are a snapshot taken 28 October 2026; the tracker page is the live version.

35candidate medicines with trial evidence
8druggable gene targets
15recent registered trials
0already approved medicines

Full trial data → The Carpal Tunnel Syndrome pipeline page on the Research Tracker has every candidate, gene target and trial, with evidence grades.

Short answer: as of October 2026, the OSMF Research Tracker lists 35 candidate medicines for carpal tunnel syndrome that are either approved medicines or have at least one registered clinical trial, built on 8 druggable gene targets, with 15 recent trials on ClinicalTrials.gov. 0 are already approved medicines, for this condition or another one; where the approval is for a different condition, the trial is testing a new use, which is what drug repurposing means. Being in a trial says an intervention is being studied, not that it works; that is what the trial is for.

Which candidates have the most trial activity?

Ranked by the number of registered trials the tracker found. Each trial ID links to the registry entry, where you can read the design, status and sponsor.

Which gene targets are these built on?

The tracker starts from genes with evidence of being druggable in carpal tunnel syndrome and asks which compounds act on them. Each symbol links to its DGIdb entry, which lists the interacting drugs and the papers behind them: IL6, NR3C1, PTGS2, SCN9A, TGFB1, TNF, TRPV1, TTR.

Which trials are registered?

Drug and biologic treatment trials whose main condition is carpal tunnel syndrome, from the tracker's ClinicalTrials.gov snapshot. Full trial data →

How to read this

Evidence is graded on the tracker page in three tiers: clinical (tested in people), mechanistic (a documented action on the target) and correlative (an association in the literature). Most candidates sit in the lower tiers, and many trials are small or early-phase. The list is restricted to medicines and supplements: trial arms that are devices, procedures, behavioural programmes or measurements are filtered out automatically, so an occasional misclassified entry is possible; the tracker page lists every arm. The purpose of this list is to show where the research is, with sources, so that patients, clinicians and researchers can look further; it is not a ranking of what to take. How sources are chosen, graded and corrected is set out in our editorial policy.

More Chronic Disease notes

Related on this site

Open the full carpal tunnel syndrome page on the Research Tracker → ← All research notes

Research information, not medical advice. Decisions about any medicine belong with you and your clinician. The underlying data are open (CC BY 4.0) and refreshed daily; this note was generated from the tracker page on 28 October 2026.

The OSMF Network